A phase 3 trial of Sodium thiosulfate in Extragonadal germ cell tumour, Hepatocellular carcinoma, Neuroblastoma and Ovarian cancer, run by Children's Oncology Group, completed.
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy is a phase 3 interventional study registered as NCT00716976 by Children's Oncology Group, with 131 participants recorded, started 2008-06-23 and reaching its primary completion in 2015-04-09. Interventions recorded: sodium thiosulfate, examination. Conditions recorded: Brain Tumor, Central Nervous System Tumor, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma.
Linked to the drug Sodium thiosulfate because the registry names it among its interventions and Extragonadal germ cell tumour, Hepatocellular carcinoma, Neuroblastoma and Ovarian cancer among its conditions. Registry record only: no result has been read by an editor.
Numbers are from the trial as recorded here; see the source links in the table below. This is orientation, not medical advice: ask your team how closely the trial population matches you.
131 enrolled.
Figures from the ClinicalTrials.gov results section (first posted 2014-02-26), not from a publication
Source95% CI 55.6 to 79.9; Figures from the ClinicalTrials.gov results section (first posted 2014-02-26), not from a publication · 95% CI 68.4 to 90.1
SourceShares Sodium thiosulfate (otoprotectant), Hearing and tinnitus after platinum chemotherapy, Hepatocellular carcinoma and the tag pipeline.
Shares Sodium thiosulfate (otoprotectant), Children's Oncology Group (COG) and the tag pipeline.
Shares Neuroblastoma (paediatric), Ovarian cancer and the tag pipeline.
Shares Neuroblastoma (paediatric) and the tag pipeline.
Shares Neuroblastoma (paediatric) and the tag pipeline.
Shares Hepatocellular carcinoma and the tag pipeline.
Shares Neuroblastoma (paediatric) and the tag pipeline.
Shares Ovarian cancer and the tag pipeline.